Skip to main content
Top
Published in: Annals of Hematology 5/2018

01-05-2018 | Original Article

Polyneuropathy and myopathy in beta-thalassemia major patients

Authors: P. Nemtsas, M. Arnaoutoglou, V. Perifanis, E. Koutsouraki, G. Spanos, N. Arnaoutoglou, P. Chalkia, D. Pantelidou, A. Orologas

Published in: Annals of Hematology | Issue 5/2018

Login to get access

Abstract

The thalassemias are the most common single gene disorder in the world. Nowadays, the average life expectancy of patients in developed countries has increased significantly, while, there was an increase of complications. We aimed to investigate peripheral neuropathy and myopathy in this patient group using a neurophysiological study. We performed nerve conduction studies and electromyography of upper and lower extremities on 36 beta-thalassemia major (β-thal) patients. The electrophysiological findings were correlated with demographic data and laboratory parameters of the disease. Patients with β-thal present polyneuropathy or myopathy at (50%). Polyneuropathy was detected in (38.9%) and myopathy in (27.8%), while polyneuropathy and myopathy were present at (16.7%) with an overlap of the diseases in 1/3 of the patients. There was not a statistically significant correlation of polyneuropathy and myopathy with age, sex, splenectomy, nor with respect to laboratory parameters, hemoglobin, and ferritin. However, there was a statistically significant correlation of polyneuropathy and myopathy with iron overload, as recorded by the magnetic resonance imaging (MRI) of the heart and the liver. Our findings suggest that iron overload plays a key role in the pathogenesis of polyneuropathy and myopathy in β-thal patients, and performing heart and liver MRI for the prediction of such lesions in an annual basis is warranted.
Appendix
Available only for authorised users
Literature
3.
go back to reference Cappellini MD, Cohen A, Eleftheriou A et al. In Guidelines for the clinical management of thalassaemia, 2nd Revised Edition. Nicosia (CY): 2008 Cappellini MD, Cohen A, Eleftheriou A et al. In Guidelines for the clinical management of thalassaemia, 2nd Revised Edition. Nicosia (CY): 2008
4.
go back to reference Nemtsas P, Arnaoutoglou M, Perifanis V et al (2015) Neurological complications of beta-thalassemia. Ann Hematol 94:1261–1265CrossRefPubMed Nemtsas P, Arnaoutoglou M, Perifanis V et al (2015) Neurological complications of beta-thalassemia. Ann Hematol 94:1261–1265CrossRefPubMed
8.
go back to reference Stamboulis E, Vlachou N, Drossou-Servou M et al (2004) Axonal sensorimotor neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry 75:1483–1486CrossRefPubMedPubMedCentral Stamboulis E, Vlachou N, Drossou-Servou M et al (2004) Axonal sensorimotor neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry 75:1483–1486CrossRefPubMedPubMedCentral
11.
go back to reference Barbara E. Shapiro DCP (2005) Electromyography and neuromuscular disorders. Elsevier Barbara E. Shapiro DCP (2005) Electromyography and neuromuscular disorders. Elsevier
12.
go back to reference J. K (2013) Electrodiagnosis in diseases of nerve and muscle principles and practice. Oxford University Press J. K (2013) Electrodiagnosis in diseases of nerve and muscle principles and practice. Oxford University Press
13.
go back to reference England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ, American Academy of Neurology, American Association of Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64(2):199–207. https://doi.org/10.1212/01.WNL.0000149522.32823.EA CrossRefPubMed England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ, American Academy of Neurology, American Association of Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64(2):199–207. https://​doi.​org/​10.​1212/​01.​WNL.​0000149522.​32823.​EA CrossRefPubMed
14.
go back to reference Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179CrossRefPubMed Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179CrossRefPubMed
15.
go back to reference Gandon Y, Olivie D, Guyader D et al (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363:357–362CrossRefPubMed Gandon Y, Olivie D, Guyader D et al (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363:357–362CrossRefPubMed
16.
go back to reference Christoforidis A, Perifanis V, Spanos G et al (2009) MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol 82:388–392CrossRefPubMed Christoforidis A, Perifanis V, Spanos G et al (2009) MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol 82:388–392CrossRefPubMed
17.
go back to reference Vlachaki E, Agapidou A, Spanos G et al (2015) Five years of deferasirox therapy for cardiac iron in beta-thalassemia major. Hemoglobin 39:299–304CrossRefPubMed Vlachaki E, Agapidou A, Spanos G et al (2015) Five years of deferasirox therapy for cardiac iron in beta-thalassemia major. Hemoglobin 39:299–304CrossRefPubMed
19.
go back to reference Ouederni M, Ben Khaled M, Mellouli F et al (2017) Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients. Ann Hematol 96:133–139CrossRefPubMed Ouederni M, Ben Khaled M, Mellouli F et al (2017) Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients. Ann Hematol 96:133–139CrossRefPubMed
20.
go back to reference Rachmilewitz EA, Weizer-Stern O, Adamsky K et al (2005) Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci 1054:118–123CrossRefPubMed Rachmilewitz EA, Weizer-Stern O, Adamsky K et al (2005) Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci 1054:118–123CrossRefPubMed
21.
go back to reference Yarjanli Z, Ghaedi K, Esmaeili A et al (2017) Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci 18:51CrossRefPubMedPubMedCentral Yarjanli Z, Ghaedi K, Esmaeili A et al (2017) Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci 18:51CrossRefPubMedPubMedCentral
25.
go back to reference Cuesta A, Pedrola L, Sevilla T, García-Planells J, Chumillas MJ, Mayordomo F, LeGuern E, Marín I, Vílchez JJ, Palau F (2002) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30(1):22–25. https://doi.org/10.1038/ng798 CrossRefPubMed Cuesta A, Pedrola L, Sevilla T, García-Planells J, Chumillas MJ, Mayordomo F, LeGuern E, Marín I, Vílchez JJ, Palau F (2002) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30(1):22–25. https://​doi.​org/​10.​1038/​ng798 CrossRefPubMed
Metadata
Title
Polyneuropathy and myopathy in beta-thalassemia major patients
Authors
P. Nemtsas
M. Arnaoutoglou
V. Perifanis
E. Koutsouraki
G. Spanos
N. Arnaoutoglou
P. Chalkia
D. Pantelidou
A. Orologas
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2018
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3251-7

Other articles of this Issue 5/2018

Annals of Hematology 5/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.